NCT06133140

Brief Summary

The investigators plan to determine whether unblinded continuous ward monitoring with the GE Portrait Mobile Monitoring Solution and nursing alerts reduces vital sign abnormalities in patients recovering from major noncardiac surgery.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
227

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Feb 2024

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 1, 2023

Completed
14 days until next milestone

First Posted

Study publicly available on registry

November 15, 2023

Completed
3 months until next milestone

Study Start

First participant enrolled

February 14, 2024

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2026

Completed
5 days until next milestone

Study Completion

Last participant's last visit for all outcomes

January 6, 2026

Completed
Last Updated

January 9, 2026

Status Verified

January 1, 2026

Enrollment Period

1.9 years

First QC Date

November 1, 2023

Last Update Submit

January 7, 2026

Conditions

Keywords

PostoperativeAnesthesiaVital signs

Outcome Measures

Primary Outcomes (3)

  • Hypoxemia

    Area of oxygen saturation defined as SpO2 ≤85%.

    48 postoperative hours.

  • Inadequate or excessive ventilation

    Area of inadequate or excessive ventilation defined as respiratory rate ≤4/min or ≥30/min.

    48 postoperative hours.

  • Bradycardia and tachycardia

    Area of inadequate or excessive heart rate defined as ≤40/min or ≥130/min.

    48 postoperative hours.

Secondary Outcomes (1)

  • The fraction of patients who have a composite of interventions potentially related to postoperative vital sign abnormalities.

    48 postoperative hours.

Study Arms (2)

Blinded monitoring

Continuous postoperative vital sign monitoring blinded to clinicians and investigators.

Device: Blinded postoperative vital sign monitoring

Unblinded monitoring

Continuous postoperative vital sign monitoring unblinded to clinicians and investigators.

Device: Unblinded postoperative vital sign monitoring

Interventions

Blinded postoperative GE Portrait monitoring

Also known as: Blinded group
Blinded monitoring

Unblinded postoperative GE Portrait monitoring

Also known as: Unblinded group
Unblinded monitoring

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients who are older than 18 years of age. Patients have a ASA status 1-4. The patients whom had a major noncardiac surgery lasting at least 1.5 hours and are expected to remain hospitalized at least two postoperative nights, and are being admitted to a ward equipped with the GE Portrait Mobile Monitor.

You may qualify if:

  • Are expected to be admitted to one of the wards equipped with the GE Portrait Mobile Monitoring Solution;
  • Are ≥18 years old;
  • Are designated American Society of Anesthesiologists physical status 1-4;
  • Are scheduled for major noncardiac surgery lasting at least 1.5 hours;
  • Are expected to remain hospitalized at least one postoperative night;
  • Are expected to have general or neuraxial anesthesia.

You may not qualify if:

  • Have language, vision, or hearing impairments that might compromise continuous monitoring;
  • Are designated Do Not Resuscitate, hospice, or receiving end of life care;
  • Are expected to have telemetry monitoring;
  • Have previously participated in the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cleveland Clinic Foundation

Cleveland, Ohio, 44195, United States

Location

MeSH Terms

Conditions

Postoperative Complications

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Ryu Komatsu, MD

    The Cleveland Clinic

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
OTHER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 1, 2023

First Posted

November 15, 2023

Study Start

February 14, 2024

Primary Completion

January 1, 2026

Study Completion

January 6, 2026

Last Updated

January 9, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will share

Data will be shared collaboratively upon approval of the Steering Committee and appropriate data-use agreement.

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
Time Frame
One year after publication of main paper.
Access Criteria
Contact PI.

Locations